Overview
Description
Knight Therapeutics Inc. is a Canadian-based specialty pharmaceutical company. Its core purpose is to develop, acquire, license, and deliver innovative pharmaceutical products to fulfill unmet medical needs. The company places a strong emphasis on the therapeutic fields of oncology, infectious diseases, and select consumer health products. Utilizing strategic partnerships, in-licensing, and acquisitions, Knight Therapeutics bolsters its product portfolio with high-potential medications that meet rigorous regulatory standards. Operating largely across Canada and Latin America, it plays a crucial role in enhancing healthcare outcomes within these geographies. The company is noteworthy for its commitment to sustainable growth and value creation in the pharmaceutical industry, and its adaptability in responding to market demands and healthcare trends solidifies its standing as a key player in the regional pharmaceutical landscape.
About
CEO
Ms. Samira Sakhia BCom, CA, CPA, MBA
Employees
745
Address
3400 de Maisonneuve Blvd. W.
Suite 1055
Montreal, H3Z 3B8, QC
Canada
Suite 1055
Montreal, H3Z 3B8, QC
Canada
Phone
514-484-4483
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
MIC code
XTSE